Health
CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News
Clinical trials based on CRISPR technology have been deferred due to potential risks, such as off-target effects, the creation…
Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…
Continue Reading
-
General9 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News23 hours agoProtest calls for shark net removal
-
General22 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
General15 hours agoTeam Australia wins back-to-back Motocross of Nations titles